D. Lavelle et al., Histone deacetylase inhibitors increase p21(WAF1) and induce apoptosis of human myeloma cell lines independent of decreased IL-6 receptor expression, AM J HEMAT, 68(3), 2001, pp. 170-178
Histone deacetylase (HDAC) inhibitors cause growth arrest and apoptosis of
cancer cells by both p21-dependent and independent mechanisms. Decreased ex
pression of growth factor receptors may be a key factor in the p21-independ
ent mechanism, although this has not been directly tested. We have tested t
he effects of sodium butyrate and trichostatin A on human myeloma cell line
s and have observed GI arrest and apoptosis associated with increased expre
ssion of p21(WAF1), Bax, Rb dephosphorylation, and decreased IL-6 receptor
(IL-6R) expression. Experiments to determine the role of disruption of IL-6
signaling as a result of decreased IL-6 receptor expression in mediating t
hese effects were conducted using a stable transfectant of the OPM-2 line w
hich constitutively expressed the IL-6 receptor. Our results indicated that
decreased IL-6R expression was not required for induction of p21(WAF1) or
apoptosis. Thus, HDAC inhibitors appear to activate multiple cellular pathw
ays, leading to growth arrest and apoptosis, and their use in the treatment
of myeloma, particularly in combination with other agents, warrants furthe
r investigation. (C) 2001 Wiley-Liss, Inc.